Scientists from Cornell University and Cornell Weill Medical College are developing a solar-powered, point-of-care PCR system that has the potential to enable electricity-free molecular diagnostics in resource-poor areas of the world.
BioHelix is developing a low-cost, handheld, real-time fluorescence detection system capable of running assays based on the company's isothermal helicase-dependent amplification technology, the company disclosed this week.
Luminex this week made a play for the low- to mid-volume molecular diagnostic testing market by when it announced that it is acquiring privately held molecular diagnostics developer GenturaDx for $50 million.
NEW YORK (GenomeWeb News) – A study online today in Science hints that the live, attenuated viruses used in some vaccines may be able to recombine in their hosts in rare cases, producing viruses that are once again able to cause infection.
Scientists from the Keck Graduate Institute of Applied Life Sciences and KGI spinout Claremont Biosolutions have been developing point-of-care molecular testing platforms and associated assays for Clostridium difficile, multi-drug-resistant tuberculosis, and herpes simpl
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – BioHelix today announced that the US Food and Drug Administration has given 510(k) clearance for its assay for the detection of herpes simplex virus.